Answers are grounded in this paper and cite their sources.
Abstract Background Smoking in pregnancy continues to cause significant morbidity to mothers and babies and contributes to tremendous costs to society. Maternal-fetal attachment (MFA) may differentiate smokers who quit or pregnant smokers from non-smokers. Researchers have recommended utilizing interventions that improve MFA to help decrease smoking within pregnancy. Methods We performed a randomized clinical trial of pregnant smokers (n = 33) using an MFA-informed, intention-to-treat protocol. We recruited pregnant smokers and provided timeline follow back (TLFB) interviews from 27 weeks of pregnancy until 6 weeks post-partum. Salivary cotinine was also collected at five different time points. 3D ultrasonography was performed, and patients were randomly assigned a 3D picture or a 3D model of their fetus. Results Overall, the average percent reduction in cigarette use was 37.03% (SD = 31.18). The main effect of 3D type was not significant (3D Model vs. 3D Print Estimate = -0.09, 95% CI: − 0.19 to 0.01, p = 0.066). A total of 4 patients (12%) quit smoking within one week of delivery. A 10% reduction in cigarette use was associated with a 30.57 g increase in birth weight (Estimate = 30.57, 95% CI: -14.15 to 75.29); a 10% reduction in cigarette use was associated with a 0.14 week increase in estimate gestational age at delivery (Estimate = 0.14, 95% CI: -0.01 to 0.28). Conclusions Patients who smoke in pregnancy decrease the number of cigarettes smoked after receiving either a 3D picture or 3D model of their fetus. Trial registration: clinicaltrials.gov (NCT04541121)
No takes yet. Share an insight, caveat, or question.
Coté et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: